2019
DOI: 10.3233/cbm-190666
|View full text |Cite
|
Sign up to set email alerts
|

TRPM7 deficiency suppresses cell proliferation, migration, and invasion in human colorectal cancer via regulation of epithelial-mesenchymal transition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(17 citation statements)
references
References 20 publications
1
16
0
Order By: Relevance
“…How inhibition of TRPM7 exerts the observed effects, such as the inhibition of EndoMT, proliferation, and vasorelaxation, remains unclear. TRPM7 has been reported to contribute to the epithelial-mesenchymal transition in ovarian, prostate, colorectal and breast cancers [28][29][30][31][32][33]. Ca 2+ influx and the subsequent activation of STAT3 or Akt in breast and ovarian cancers, respectively, and Mg 2+ influx in prostate cancer have been suggested to support the TRPM7-mediated epithelial-mesenchymal transition [28,29,32].…”
Section: Discussionmentioning
confidence: 99%
“…How inhibition of TRPM7 exerts the observed effects, such as the inhibition of EndoMT, proliferation, and vasorelaxation, remains unclear. TRPM7 has been reported to contribute to the epithelial-mesenchymal transition in ovarian, prostate, colorectal and breast cancers [28][29][30][31][32][33]. Ca 2+ influx and the subsequent activation of STAT3 or Akt in breast and ovarian cancers, respectively, and Mg 2+ influx in prostate cancer have been suggested to support the TRPM7-mediated epithelial-mesenchymal transition [28,29,32].…”
Section: Discussionmentioning
confidence: 99%
“…The downregulation of TRPM7 suppressed CRC cell proliferation, migration, and invasion, as well as triggered cell cycle arrest in the G0/G1 phase, reduced the S phase, and promoted apoptosis. Furthermore, the decrease in TRPM7 expression in CRC cells reversed EMT, which was accompanied by a downregulation in N-cadherin and an upregulation of E-cadherin expression [151]. Mg 2+ homeostasis regulation via TRPM6 and TRPM7 was also linked to the sensitivity of CRC cells to doxorubicin, a common chemotherapeutic agent.…”
Section: Colorectal Cancermentioning
confidence: 93%
“…Indeed, it was reported that TRPM6 is downregulated in CRC tissues on mRNA level [120,123], and its higher expression is correlated with an increased overall survival [123]. On the other hand, TRPM7 was suggested to be upregulated in CRC on mRNA level [151]. Moreover, a single-nucleotide polymorphism that substitutes TRPM7 threonine 1482 for isoleucine (T1482I) increases the risk of the development of colon cancer, particularly in patients with a high Ca 2+ /Mg 2+ ratio [152].…”
Section: Colorectal Cancermentioning
confidence: 99%
“…Furthermore, Huang et al show that the TRPM7 channel is the main transporter for Mg 2+ influx in both the HT-29 CRC cell line and in primary mouse colon epithelial cells. Su et al also show that TRPM7 silencing decreases both HT-29 and SW-480 cell proliferation, migration and invasion [82]. Inhibition of TRPM7 induces the upregulation of E-cadherin and the downregulation of N-cadherin in CRC cells suggesting that this channel may regulate epithelial-to-mesenchymal transition (EMT).…”
Section: Regulation Of Digestive Cancer Cell Fates By Magnesium Transportersmentioning
confidence: 97%
“…TRPM7 was also found upregulated in CRC using in silico datasets but also qRT-PCR, immunofluorescence, and IHC on tissues. TRPM7 expression was also associated with tumor infiltration, tumor grade, and the presence of distant metastasis [81,82]. In qRT-PCR-based and in silico studies, the Mg 2+ transporter MAGT1 was found to be overexpressed in colorectal cancerous tissues [83].…”
Section: Analysis Of the Literaturementioning
confidence: 99%